Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would: (1) better inform decisions and plans of those responsible for developing new cancer therapies (2) more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic (3) be less costly than current trials The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward.
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Board on Health Care Services, National Cancer Policy Forum, Sharyl Nass, Anne Frances Johnson, Jennifer Zhu, Erin Balogh
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl Nass, Melissa Maitin-Shepard, Erin Balogh, Francis Amankwah
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, and Independence Forum on Aging, Disability, National Cancer Policy Forum, Sharyl Nass, Margie Patlak, Francis Amankwah
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Sharyl Nass, Anne Frances Johnson, Erin Balogh, Francis Amankwah
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, Board on Health Care Services, Roundtable on Genomics and Precision Health, National Cancer Policy Forum, Sharyl Nass, Anne Johnson, Marc Meisnere
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Division on Engineering and Physical Sciences, Division of Behavioral and Social Sciences and Education, Computer Science and Telecommunications Board, Board on Human-Systems Integration, Board on Health Care Services, National Cancer Policy Forum, Sharyl Nass, Theresa Wizemann, Laurene Graig, Erin Balogh
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, Roundtable on Health Literacy, National Cancer Policy Forum, Sharyl Nass, Joe Alper, Erin Balogh, Emily Zevon
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Care Services, Roundtable on the Promotion of Health Equity, National Cancer Policy Forum, Sharyl Nass, Theresa Wizemann, Francis Amankwah, Erin Balogh
and Medicine National Academies of Sciences, Engineering, Division on Engineering and Physical Sciences, Health and Medicine Division, Computer Science and Telecommunications Board, Board on Health Care Services, National Cancer Policy Forum, Sharyl Nass, Theresa Wizemann, Frances Amankwah, Erin Balogh